An observational study in Cardiac Arrest, Out-Of-Hospital, sponsored by University Hospital, Ghent. Recruiting at 9 sites in 8 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-18.
Sponsored by University Hospital, Ghent · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Out-of-Hospital Cardiac Arrest with a site in Belgium — 4 open to participants now, 5 under way, 1 of them phase 3. Out-of-Hospital Cardiac Arrest · Belgium.
Among the 13 studies in Out-of-Hospital Cardiac Arrest with a site in Belgium, this one is one of 2 that started in 2025, is one of 4 observational ones, and was the 11th registered.
314 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 93 are open to participants now.
Browse Out-of-Hospital Cardiac Arrest studies →4 of the 13 studies in Out-of-Hospital Cardiac Arrest with a site in Belgium are open now. Recruiting first, the newest first:
University Hospital, Ghent · Sites in Belgium, France
Ages 18+
Karolinska Institutet · Sites in Belgium, Austria, Germany and 5 more countries
Ages 18–79
University Hospital, Ghent · Sites in Belgium
Ages 18+
A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →
Of the 66 Out-of-Hospital Cardiac Arrest studies recruiting now, 46 (70%) set no upper age limit and 13 (20%) stop at 75 or younger; 8 take children under 18; 7 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 2 started in 2025.
This study's planned enrollment of 1,000 is above the median of 300 across 128 observational studies indexed under Out-of-Hospital Cardiac Arrest.
Median enrollment 700 across the 9 interventional studies, 90 across the 4 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 13 have an industry lead sponsor. The 10 most frequent:
University Hospital, Ghent is the lead sponsor of 689 studies on the registry; 157 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.
University Hospital, Ghent has 3 studies filed under Out-of-Hospital Cardiac Arrest — fewer than ten, so there is no comparison to draw.
2 of the studies in Out-of-Hospital Cardiac Arrest with a site in Belgium that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07579390Helsinki University Central HospitalEffects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE) | 2026-12 |
| NCT07026773University Hospital, GhentValidity of ICU Clinician's Appraisal of Proportionality in CPR | 2026-12-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 13 studies in Out-of-Hospital Cardiac Arrest with a site in Belgium, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The VICAP-CPR study investigates whether doctors and nurses working in Intensive Care can determine neurological outcome and future quality of life after six months in patients treated for cardiac arrest outside the hospital based on clinical assessment in the first 24 hours after admission to Intensive Care. To conduct this study, the results of the questionnaire offered to Intensive Care doctors and nurses regarding the estimation of long-term neurological outcome and quality of life will be compared with the neurological outcome and quality of life as recorded in the STEPCARE study (NCT 05564754). The aim of the international STEPCARE study is to determine the best combination of post-resuscitation care to favourably influence survival and neurological outcome in patients treated for cardiac arrest outside hospital.
In the guidelines 2021 of the European Resuscitation Council it is acknowledged that apart from criteria related to the cardiac arrest circumstances, additional criteria can be used to support resuscitation decisions. For instance, the presence of severe chronic comorbidities or a very poor quality of life prior to cardiac arrest are allowed to support decisions to stop or not start resuscitation in unwitnessed out-of-hospital cardiac arrest (OHCA) with an initial non-shockable rhythm. In current clinical practice, these factors are often not taken into account and patients with severe underlying comorbidities and poor general condition are also resuscitated. In intensive care, a wait-and-see approach is then usually adopted until additional information is gathered about the patient's likely prognosis based on repetitive clinical neurological examination, electrophysiological tests such as electro-encephalography and somatosensory evoked potentials, biomarker analysis and cerebral imaging (multimodal neuroprognostication).
At the ICU level, both physicians and nurses can have valuable insights into what the likely prognosis is of the OHCA patients they are treating. In subgroups with a poor prognosis (e.g. non-shockable unwitnessed arrest in older patient) the added value of the multimodal ICU neuroprognostication is potentially very limited or absent. The implication for intensive care could be that policy decisions could perhaps be made earlier in several situations. Exploring the prognostic value of the clinical perception of ICU physicians and ICU nurses regarding appropriateness of CPR and their prognostication of neurological outcome and quality of life relative to multimodal ICU neuroprognostication might help to refine the ethical guidance towards resuscitation decision making and towards ICU management after ROSC in general.
The study aims are:
Statistical analysis Associations between the perception of ICU physicians and ICU nurses regarding appropriateness of CPR, on the one hand, and the ICU clinician's perceived presence of frailty, severe comorbidities, quality of life, as well as objective factors related to the OHCA (shockable rhythm, bystander CPR, witnessed arrest) and clinician characteristics (age, gender, years of experience and professional background), on the other hand, will be estimated (in terms of conditional odds ratios) using a generalised linear mixed effects model (with 'logit' link and a random intercept for center and for patient) to allow statistical inference (estimation of corresponding standard errors and confidence intervals) that correctly accounts for the multilevel structure of the data (i.e. clinicians clustered within patients, patients clustered within centers).
Subsequently, the concordance between clinicians' combined perception of inappropriateness of CPR (A) and the result of the multimodal ICU neuroprognostication (Y) will be assessed by estimating the following predictive metrics with Y being the outcome and A being the predictor:
Subsequently, the prognostic value of clinicians' combined perception of inappropriate CPR and the clinician's prognostication with respect to the primary composite endpoint (alive with a good functional outcome and good quality of life as defined in STEPCARE) will be assessed in terms of the PPV, NPV and AUC. Additionally, the added or incremental prognostic value of the multimodal ICU neuroprognostication above and beyond that of ICU clinicians' combined perception of inappropriate CPR and the clinician's prognostication will be assessed in terms of increase in AUC. More specifically, two logistic regression model will be fitted: a logistic regression model for the primary outcome with clinicians' combined perception of inappropriate CPR, the clinician's prognostication as only predictor (model 1), and a logistic regression model for the primary outcome with clinicians' combined perception of inappropriate CPR, the clinician's prognostication and the result of the multimodal ICU neuroprognostication (and their interaction) as predictors (model 2). The AUCs of these models will be reported, as well as their respective PPV and NPV. AUC of model 2 minus AUC of model 1 will be estimated and used as a metric to quantify the added prognostic value. These analyses will be conducted for the entire study population, as well as in separate subgroups of patients with shockable versus non-shockable initial rhythms. For this analysis, whenever patients were discharged alive or died before the multimodal ICU neuroprognostication could be conducted or completed, results of the multimodal ICU neuroprognostication will be imputed in such a way that their coding is identical to that of the corresponding clinicians' combined perception of inappropriate CPR to reflect the fact that, in such cases, multimodal ICU neuroprognostication can by definition not have any added prognostic value. Ideally, the multilevel nature of the data will be accounted for when estimating these metrics and their respective confidence intervals.
The study will collect additional data apart from the STEPCARE study (NCT 05564754):
ICU doctors and nurses treating the patient in the first 24 hours after ICU admission are requested to complete a short (less than 3 minutes) survey, ideally as soon as possible since we are interested in the predictive value of clinical appraisal of the ICU doctor and ICU nurse.
The survey comprises questions regarding clinician characteristics, perception regarding frailty, quality of life, comorbidities, appropriateness of CPR and prognostication of the outcome 6 months after OHCA.
The study population are doctors and nurses working in an Intensive Care Unit treating a patient included in the STEPCARE study (NCT 05564754) during the first 24 hours after admission to Intensive Care
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Composite endpoint of survival, good functional outcome and good quality of life 6 months after OHCA
Good functional outcome defined as modified Rankin scale 0 - 3; quality of life based on EuroQol-VAS
Time frame: 6 months after return of spontaneous circulation
Assessment of a likely poor neurological outcome based on the multimodal ICU neuroprognostication as performed in the Stepcare study NCT 05564754
Stepcare criteria for a likely poor neurological outcome are fulfilled yes or no
Time frame: More than 72 hours after randomisation in the Stepcare study NCT 05564754
Plan to share: Undecided
Started May 2025 (actual). Primary completion is estimated for Dec 2026, 19 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Out-of-Hospital Cardiac Arrest →